Daewoong Pharmaceutical said it has signed a three-way memorandum of understanding (MOU) with Seer Technology and PuzzleAI to jointly develop and deploy generative AI-based smart hospital solutions, aiming to enhance operational efficiency and patient-centered care in clinical settings.

The agreement, signed at Daewoong’s headquarters on Wednesday, seeks to integrate cutting-edge digital healthcare technologies such as voice-enabled clinical documentation, AI-powered medical record automation, and real-time patient monitoring across diverse hospital environments.

Under the partnership, the three companies will work together to promote widespread adoption of their solutions in hospitals, develop advanced clinical systems linked to smart bed platforms, and establish personalized healthcare models based on patient data. Their long-term goal is to build a future-ready digital healthcare ecosystem in Korea and potentially expand globally.

As part of the agreement, PuzzleAI will provide “GenNote,” a generative AI-driven medical documentation solution that automatically recognizes and summarizes physicians’ speech in real time. The system is designed to support various hospital environments, including inpatient wards, outpatient clinics, operating rooms, and intensive care units. It also enables direct integration with electronic medical record (EMR) systems.

Seer Technology will lead the development of technologies to integrate its “THINK” smart bed monitoring system with GenNote, while advancing the solution through clinical validation and pilot studies. Daewoong Pharmaceutical will focus on promoting and marketing the integrated solution to hospitals and medical institutions.

“Digital healthcare is a core future growth engine for Daewoong Pharmaceutical,” Daewoong CEO Lee Chang-jae said. “We are committed to building a competitive digital health ecosystem with global scalability.”